|
Volumn 3, Issue 3, 1988, Pages 213-219
|
Low molecular-weight heparin (CY216) in the treatment of venous thromboembolism in patients at high risk for bleeding complications
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
LOW MOLECULAR WEIGHT HEPARIN;
NADROPARIN;
WARFARIN;
HEPARIN;
HEPARIN, LOW MOLECULAR WEIGHT;
ADULT;
AGED;
BLEEDING TENDENCY;
BRAIN HEMORRHAGE;
CLINICAL ARTICLE;
DRUG EFFICACY;
EMERGENCY TREATMENT;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
ORAL DRUG ADMINISTRATION;
RETROPERITONEAL HEMORRHAGE;
RISK FACTOR;
THROMBOEMBOLISM;
VEIN THROMBOSIS;
ARTICLE;
BLEEDING;
CASE REPORT;
DRUG ADMINISTRATION;
IATROGENIC DISEASE;
LUNG EMBOLISM;
THROMBOPHLEBITIS;
ADULT;
AGED;
CASE REPORT;
DRUG ADMINISTRATION SCHEDULE;
ENGLISH ABSTRACT;
FEMALE;
HEMORRHAGE;
HEPARIN;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HUMAN;
PULMONARY EMBOLISM;
RISK FACTORS;
THROMBOPHLEBITIS;
|
EID: 0024038724
PISSN: 03939394
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|